SEC Form D private-offering filing

CeleCor Therapeutics, Inc.

Name: CeleCor Therapeutics, Inc. - new SEC Form D private-offering filing, Del Mar, CA
Published: 2026-07-09

A new SEC Form D private-offering notice from Del Mar, CA, a $15,000,000 filer-stated offering target in Biotech. The source filing is one click away.

CeleCor Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage pharmaceutical company developing zalunfiban, a pre-hospital anti-platelet drug for STEMI heart attacks

Filed 2026-07-09Filed to raise $15,000,000First money in 2026-06-09Raised so far $11,856,325HQ (as filed) Del Mar, CASector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified celecor.com↗Named in the filing 4 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.